BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

 

May 2006

STUDY IN THE JOURNAL VACCINE REPORTS POSITIVE RESULTS OF DNA-BASED FLU VACCINE IN HUMANS

Sigma-Aldrich Announces Service Provider for Whole Genome Amplification Technology

deltaDOT announces the launch of Merlin - a major step forward in low-cost rapid-throughput DNA sequencing

West launches New High Performance Elastomeric Formulation for Needle Shields and Tip Caps

European Biotech industry figures show signs of chronic under-funding

Localized delivery of PDE-4 inhibitors to open the therapeutic window

Trophos Appoints Jacques Essinger as President of Supervisory Board

Immutep Announces that ImmuFact(R) has Successfully Completed Phase I Studies

BioProgress: Update on MRSA containment system and other patent filings

Phosphagenics announces positive preclinical trial results for its transdermal insulin formulation

CeNeS announces the publication of an important independent review of its lead product, M6G

OXFORD GENE TECHNOLOGY (OGT) LAUNCHES ITS FIRST MICROARRAY PRODUCT

Sigma-Aldrich and Rosetta Inpharmatics Establish Partnership for siRNA Design

New 2D Gel Imaging Study comparing CCD Imager with Laser Scanner Shows CCD Imager Produces same Image Quality 10 Times Faster

European Ag Ministers agree to coexistence of biotech, non-biotech and organic crop production

Phosphagenics announces plans to expand its manufacturing capabilities

OXFORD BIOMEDICA COMMENCES PHASE II TRIAL OF TROVAX IN PROSTATE CANCER

EuroGentest announces European Cytogenetics EQA pilot scheme and BRCA test evaluation at ESHG

Syrris expands calorimetry team as sales increase

Syncroscopy and Leica Microsystems Sign Major Licensing Deal Allowing Leica to Offer Auto-Montage Pro as part of LAS Software

The next generation of interferons needs improvement in efficacy and safety

SOLEXA FILES $100 MILLION SHELF REGISTRATION

ABLYNX APPOINTS WIM OTTEVAERE AS CHIEF FINANCIAL OFFICER

INTEGRAGEN APPOINTS JÖRG LEENINGS AS HEAD OF SALES AND MARKETING OF ITS GERMAN COMPETENCE CENTRE FOR GENETIC DIABETES TESTING

SOLEXA ADDED TO NASDAQ BIOTECH INDE

SOLEXA REPORTS FIRST QUARTER FINANCIAL RESULTS

SOLVO’s success in the framework of the Oszkár Asbóth Focus Sector Innovation Program 2005

Thermo Expands HeavyPeptide AQUA Range for Absolute Quantification in Proteomics

InSecta and Imperial College to work together on Medfly SIT

Ground-breaking new SZX2 stereo microscope series launched by Olympus

Olympus introduces the advanced scan^R Screening Station for Life Science

BioProgress announces the OTC launch of sore throat treatment, Collunovar for Dexo France

Peakdale Molecular Launches New Website

Inpharmatica announces ISO 9001 Certification for its ADME business

IDBS joins SAFE-BioPharma Association's Vendor Partner Program

OXFORD BIOMEDICA SECURES AGREEMENT WITH FDA ON SPECIAL PROTOCOL ASSESSMENT FOR PHASE III TRIAL OF TROVAX IN RENAL CANCER

Biacore launches its Own Operation in China

Diatos Announces Acquisition of Specialty Cancer Product DaunoXomeR from Gilead Sciences

SOLEXA TO HOLD FIRST QUARTER 2006 FINANCIAL RESULTS CONFERENCE CALL ON MAY 15

Santaris Pharma to present at Rodman & Renshaw 3rd Annual Global Healthcare Conference - May 15th 2006

Advanced reader copies of 2nd edition of Building Biotechnology

RNA interference (RNAi) is coming of age as a therapeutic modality

The Flow Liquid-Liquid EXtraction module (FLLEX) for compound purification

Isogenica enters into a research collaboration agreement with GE Healthcare

Phosphagenics initiates Phase 2a clinical trial of its transdermal morphine cream

POSITIVE RESULTS FOR ACRUX'S MENOPAUSE SPRAY IN US PHASE III TRIAL

Studies presented at EUROGIN highlight potential of p16INK4a as biomarker for screening and diagnosis of cervical cancer

Pharma's growing concern over parallel trade

BioMedical Diagnostics SA (France) and Modules for Novel Diagnostics Ltd (Israel) sign research agreement covering infectious disease Multiplex assays

Soluble LAG-3 molecule amplifies tumor-specific immunity

CellCentric receives Ł1.15m DTI award

SOLEXA TO PRESENT AT LEERINK SWANN & COMPANY/MEDACORP EMERGING LIFE SCIENCE TOOLS PRODUCTS AND APPLICATIONS ROUNDTABLE

York Pharma: Interim Results for the Six Months Ended 31st March 2006

Accelerating Innovations in Drug Discovery

Drug Patent Expirations in May 2006

Cobra Biomanufacturing Signs Manufacturing Agreement with the International AIDS Vaccine Initiative and GlaxoSmithKline

OXFORD BIOMEDICA REPORTS ENCOURAGING PRECLINICAL DATA WITH RETINOSTATR IN RETINOPATHY AND DEMONSTRATES THE POTENTIAL OF LENTIVECTORR IN OTHER OCULAR DISEASES

mtm laboratories and Dako restructure license agreement regarding p16INK4a CINtecR

Santaris Pharma: New MicroRNA Cancer Research Collaboration

Opportunities in Stem Cell Research and Commercialization Technology advances, regulatory impact and key players

The Top 10 Generics Companies Strategic insight, growth opportunities and competitive dynamics in the US and Europe

The Pharmaceutical Industry Key events and trends shaping its current status and future direction

PHOSPHAGENICS & NESTLÉ NUTRITION SIGN AGREEMENT FOR DEVELOPMENT OF PHOSPHA E® FOR FOODS AND BEVERAGES

International Biotechnology Trust plc flying high as it outperforms all indices in its first half

BioNewsCast Press Release Service 2006 Archive - January 2006 ~ February 2006 ~ March 2006 ~ April 2006 ~ May 2006 ~ June 2006 ~ July 2006 ~ August 2006

BioNewsCast Press Release Service 2005 Archive - December 2005 ~ November 2005 ~ October 2005

BioNewsCast Press Release Service 2004 Archive

BioNewsCast Press Release Service 2003 Archive

BioNewsCast Press Release Service 2002 Archive

Site Map - new news site

Site Map - old news site
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.